The FluMist vaccine, manufactured by AstraZeneca, was approved in 2003 for health care providers to give patients, but the method has gotten renewed attention due to a new, broader approval. On Friday ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...

AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...

FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...

I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...

The FDA approved FluMist, a nasal spray flu vaccine for self-administration, making it the first flu vaccine of its kind available for at home use.

The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...

The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...

The FluMist vaccine will be able to be ordered from an online pharmacy, but it will still require a prescription. Meanwhile, U.S. covid levels decline, while whooping cough cases surge.

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...

· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...

Since its initial US approval in 2003, 200 million doses of FluMist have been distributed globally. The new ...